ATHX vs. CALA, APVO, AMPE, SCPS, ALLR, ADTX, BLPH, SXTC, EVFM, and EVLO
Should you be buying Athersys stock or one of its competitors? The main competitors of Athersys include Calithera Biosciences (CALA), Aptevo Therapeutics (APVO), Ampio Pharmaceuticals (AMPE), Scopus BioPharma (SCPS), Allarity Therapeutics (ALLR), Aditxt (ADTX), Bellerophon Therapeutics (BLPH), China SXT Pharmaceuticals (SXTC), Evofem Biosciences (EVFM), and Evelo Biosciences (EVLO). These companies are all part of the "pharmaceutical preparations" industry.
Athersys (NASDAQ:ATHX) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, community ranking, dividends and analyst recommendations.
Athersys has a beta of -0.9, meaning that its stock price is 190% less volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -0.17, meaning that its stock price is 117% less volatile than the S&P 500.
Athersys received 24 more outperform votes than Calithera Biosciences when rated by MarketBeat users. Likewise, 60.73% of users gave Athersys an outperform vote while only 59.82% of users gave Calithera Biosciences an outperform vote.
19.4% of Athersys shares are held by institutional investors. 0.0% of Athersys shares are held by insiders. Comparatively, 6.6% of Calithera Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Athersys had 1 more articles in the media than Calithera Biosciences. MarketBeat recorded 2 mentions for Athersys and 1 mentions for Calithera Biosciences. Athersys' average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.
Calithera Biosciences has higher revenue and earnings than Athersys.
Summary
Athersys and Calithera Biosciences tied by winning 5 of the 10 factors compared between the two stocks.
Get Athersys News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATHX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Athersys Competitors List
Related Companies and Tools
